Don’t miss our upcoming webinars: Subscribe today!
In this webinar:
Join CCSN and Marjut Huotari, VP-Healthcare Insights at Leger, as we present the results of the COVID-19 and Cancer Care Disruption in Canada Survey and hear from members of the cancer community about how the pandemic has directly impacted them.
View the video:
https://youtu.be/6ub1ot806-A
To learn more about CCSN, visit us at survivornet.ca
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
On September 3, 2015, Ovarian cancer survivors and FDA Patient Representatives Peg Ford, Susan Leighton and Annie Ellis were invited to provide the patient perspective at the recent Ovarian Cancer Endpoints Workshop hosted by the Food and Drug Administration (FDA). This meeting was co-sponsored by the Society of Gynecologic Oncology (SGO), the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO). Many important topics to the ovarian cancer community were discussed, including novel clinical trial designs, biomarkers, and new classes of agents such as immunotherapies.
Living with Advanced Breast Cancer: Challenges and Opportunitiesbkling
Musa Mayer -- breast cancer survivor, advocate, and author -- presents at SHARE in November 2011. To view a video about the First International Consensus on Metastatic Breast Cancer, visit www.sharecancersupport.org/mayer.
Don’t miss our upcoming webinars: Subscribe today!
In this webinar:
Join CCSN and Marjut Huotari, VP-Healthcare Insights at Leger, as we present the results of the COVID-19 and Cancer Care Disruption in Canada Survey and hear from members of the cancer community about how the pandemic has directly impacted them.
View the video:
https://youtu.be/6ub1ot806-A
To learn more about CCSN, visit us at survivornet.ca
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
On September 3, 2015, Ovarian cancer survivors and FDA Patient Representatives Peg Ford, Susan Leighton and Annie Ellis were invited to provide the patient perspective at the recent Ovarian Cancer Endpoints Workshop hosted by the Food and Drug Administration (FDA). This meeting was co-sponsored by the Society of Gynecologic Oncology (SGO), the American Association for Cancer Research (AACR) and the American Society of Clinical Oncology (ASCO). Many important topics to the ovarian cancer community were discussed, including novel clinical trial designs, biomarkers, and new classes of agents such as immunotherapies.
Living with Advanced Breast Cancer: Challenges and Opportunitiesbkling
Musa Mayer -- breast cancer survivor, advocate, and author -- presents at SHARE in November 2011. To view a video about the First International Consensus on Metastatic Breast Cancer, visit www.sharecancersupport.org/mayer.
Cancer genetic testing and risk assessment overview.
This slide deck was the basis of a presentation to nurse practitioners and genetic counselors who are actively identifying and managing women at high risk of breast and ovarian cancer.
Why was screening implemented?
What is overdiagnosis?
The evidence for overdiagnosis
Available data
Facts from recent studies
Risks of screening
The illusion of early detection
Harms due to overdiagnosis
Benefit-risk balance
So, what to do?
About mammograms: https://desdaughter.wordpress.com/tag/mammograms/
About overdiagnosis: https://desdaughter.wordpress.com/tag/overdiagnosis/
About screening: https://desdaughter.wordpress.com/tag/screening/
Don't miss our upcoming webinars! Subscribe today!
In this webinar, Dr. Durand will review the changing landscape of HPV-related diseases and cancers. She will discuss methods of HPV prevention for current cancer patients and cancer survivors. Attendees will learn about the evidence for HPV vaccination in adults. Practical tips will be provided on how to access HPV vaccination.
View the YouTube video: https://youtu.be/wFgpmqOpzC4
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Knowledge, Attitude and Practice toward Cervical Cancer and Cervical Cancer S...ijtsrd
BACKGROUND Invasive Cervical Cancer ICC has been identified as the second most common cause of morbidity and mortality compared to other cancers among women in Cameroon. Cervical cancer can be treated e ectively if diagnosed early. Less than half the number of participants presented with good practice.The correlation between participants’ knowledge, attitude and practice showed that there was a significant association which therefore provides sufficient evidence to reject the null hypothesis. The result obtained in this study indicates how useful it will be to establish health education programs to increase women’s awareness and knowledge about cervical cancer. Fongang Che Landis | Enow-Orock George | Njajou Omer | Ngowe Ngowe Marcelin "Knowledge, Attitude and Practice toward Cervical Cancer and Cervical Cancer Screening and Its Associated Factors among Women in the City of Bamenda, Cameroon" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-4 , June 2021, URL: https://www.ijtsrd.compapers/ijtsrd43667.pdf Paper URL: https://www.ijtsrd.commedicine/other/43667/knowledge-attitude-and-practice-toward-cervical-cancer-and-cervical-cancer-screening-and-its-associated-factors-among-women-in-the-city-of-bamenda-cameroon/fongang-che-landis
Dr. Maurie Markman, President of Science and Medicine at Cancer Treatment Centers of America, shares his expertise on the latest developments in immunotherapy for ovarian cancer.
Cancer screening - Evidence, Expected benefits, Methods and Current Recommend...Alok Gupta
The presentation discusses about Cancer screening - Evidence, Expected benefits, Methods and Current Recommendations.
The was presented in HEALTH CONNECT meeting at Max Hospital, Saket, new Delhi in 2016.
Don't miss our upcoming webinars: Subscribe today!
In this webinar:
Dr. Paula Gordon will share information on when individuals should start screening for breast cancer, and how often to screen - in order for cancer to be found as early as possible, and to allow the least aggressive options for treatment. Dr. Gordon will also discuss how to screen for recurrence in women who’ve had cancer, explain why these methods are not always offered, and suggest what you can do to improve access to optimal screening.
View the video: https://youtu.be/7uFksz6_4Zk
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Cancer genetic testing and risk assessment overview.
This slide deck was the basis of a presentation to nurse practitioners and genetic counselors who are actively identifying and managing women at high risk of breast and ovarian cancer.
Why was screening implemented?
What is overdiagnosis?
The evidence for overdiagnosis
Available data
Facts from recent studies
Risks of screening
The illusion of early detection
Harms due to overdiagnosis
Benefit-risk balance
So, what to do?
About mammograms: https://desdaughter.wordpress.com/tag/mammograms/
About overdiagnosis: https://desdaughter.wordpress.com/tag/overdiagnosis/
About screening: https://desdaughter.wordpress.com/tag/screening/
Don't miss our upcoming webinars! Subscribe today!
In this webinar, Dr. Durand will review the changing landscape of HPV-related diseases and cancers. She will discuss methods of HPV prevention for current cancer patients and cancer survivors. Attendees will learn about the evidence for HPV vaccination in adults. Practical tips will be provided on how to access HPV vaccination.
View the YouTube video: https://youtu.be/wFgpmqOpzC4
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
Knowledge, Attitude and Practice toward Cervical Cancer and Cervical Cancer S...ijtsrd
BACKGROUND Invasive Cervical Cancer ICC has been identified as the second most common cause of morbidity and mortality compared to other cancers among women in Cameroon. Cervical cancer can be treated e ectively if diagnosed early. Less than half the number of participants presented with good practice.The correlation between participants’ knowledge, attitude and practice showed that there was a significant association which therefore provides sufficient evidence to reject the null hypothesis. The result obtained in this study indicates how useful it will be to establish health education programs to increase women’s awareness and knowledge about cervical cancer. Fongang Che Landis | Enow-Orock George | Njajou Omer | Ngowe Ngowe Marcelin "Knowledge, Attitude and Practice toward Cervical Cancer and Cervical Cancer Screening and Its Associated Factors among Women in the City of Bamenda, Cameroon" Published in International Journal of Trend in Scientific Research and Development (ijtsrd), ISSN: 2456-6470, Volume-5 | Issue-4 , June 2021, URL: https://www.ijtsrd.compapers/ijtsrd43667.pdf Paper URL: https://www.ijtsrd.commedicine/other/43667/knowledge-attitude-and-practice-toward-cervical-cancer-and-cervical-cancer-screening-and-its-associated-factors-among-women-in-the-city-of-bamenda-cameroon/fongang-che-landis
Dr. Maurie Markman, President of Science and Medicine at Cancer Treatment Centers of America, shares his expertise on the latest developments in immunotherapy for ovarian cancer.
Cancer screening - Evidence, Expected benefits, Methods and Current Recommend...Alok Gupta
The presentation discusses about Cancer screening - Evidence, Expected benefits, Methods and Current Recommendations.
The was presented in HEALTH CONNECT meeting at Max Hospital, Saket, new Delhi in 2016.
Don't miss our upcoming webinars: Subscribe today!
In this webinar:
Dr. Paula Gordon will share information on when individuals should start screening for breast cancer, and how often to screen - in order for cancer to be found as early as possible, and to allow the least aggressive options for treatment. Dr. Gordon will also discuss how to screen for recurrence in women who’ve had cancer, explain why these methods are not always offered, and suggest what you can do to improve access to optimal screening.
View the video: https://youtu.be/7uFksz6_4Zk
Follow CCSN on social media:
Twitter - https://twitter.com/survivornetca
Facebook - https://www.facebook.com/CanadianSurvivorNet
Instagram: https://www.instagram.com/survivornet_ca/
Pinterest - https://www.pinterest.com/survivornetwork
About this Webinar: This talk will explore breast screening for women 40-49. The benefits and harms for screening will be discussed, as well as what is unique about breast cancer in women in their 40s. In order to understand the controversy around current guidelines recommending against screening women 40-49, we will review the evidence upon which these guidelines are based, and their impact on breast cancer outcomes for these women.
Report Back from SGO 2023: What’s New in Cervical Cancer?bkling
Curious about what’s new in cervical cancer research? Join Dr. Evelyn Cantillo, gynecologic oncologist at Weill Cornell Medicine, as she shares the latest updates from the Society of Gynecologic Oncology (SGO) 2023 Annual Meeting on Women’s Cancer. Dr. Cantillo will also highlight what the research presented at the conference means for you and answer your questions about the new developments.
Navigating the Health Insurance Market_ Understanding Trends and Options.pdfEnterprise Wired
From navigating policy options to staying informed about industry trends, this comprehensive guide explores everything you need to know about the health insurance market.
We understand the unique challenges pickleball players face and are committed to helping you stay healthy and active. In this presentation, we’ll explore the three most common pickleball injuries and provide strategies for prevention and treatment.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
Struggling with intense fears that disrupt your life? At Renew Life Hypnosis, we offer specialized hypnosis to overcome fear. Phobias are exaggerated fears, often stemming from past traumas or learned behaviors. Hypnotherapy addresses these deep-seated fears by accessing the subconscious mind, helping you change your reactions to phobic triggers. Our expert therapists guide you into a state of deep relaxation, allowing you to transform your responses and reduce anxiety. Experience increased confidence and freedom from phobias with our personalized approach. Ready to live a fear-free life? Visit us at Renew Life Hypnosis..
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Antibiotic Stewardship by Anushri Srivastava.pptxAnushriSrivastav
Stewardship is the act of taking good care of something.
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels.
ACCORDING TO apic.org,
Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms.
ACCORDING TO pewtrusts.org,
Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate
According to WHO,
Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials
In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis.
Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites
VISION
Being proactive
Supporting optimal animal and human health
Exploring ways to reduce overall use of antimicrobials
Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way
GOAL
to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come.
being to preserve human and animal health and the effectiveness of antimicrobial medications.
to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory
to prevent antimicrobial overuse, misuse and abuse.
to minimize the developme
QA Paediatric dentistry department, Hospital Melaka 2020Azreen Aj
QA study - To improve the 6th monthly recall rate post-comprehensive dental treatment under general anaesthesia in paediatric dentistry department, Hospital Melaka
Navigating Challenges: Mental Health, Legislation, and the Prison System in B...Guillermo Rivera
This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
2. BURDEN OF CANCER IN INDIA
• India has nearly three times the incidence of US and China for head
and neck and cervical cancers.
• Real cancer incidence in India is conservatively estimated to be 1.5 to
2.0 times higher than the reported incidence by Indian cancer
registries i.e. 1.1 million in 2015.
• India’s age-standardized cancer incidence estimated at 150-200 per
100,000 population is higher than Africa and on par with China.
• Breast and cervical cancers among women, and head and neck, lung
and gastrointestinal cancers among men, represent >60% of the
incidence burden.
Ref: Call for Action: Expanding cancer care in India. 2015. Executive Summary.
2
12. REPORTED CANCER INCIDENCE IN INDIA
IS ESTIMATED TO INCREASE FROM;
90 PER 100,000 POPULATION TO 130-
170 PER 100,000 POPULATION BY 2020,
WHICH WILL MIRROR INCIDENCE RATES
OF CHINA AND OTHER DEVELOPING
COUNTRIES. 12
13. MORTALITY RATES OBSERVED IN INDIA
CAN BE ATTRIBUTED TO POOR DIAGNOSIS
AND INADEQUATE TREATMENT
13
15. KEY FACTORS IMPACTING MORTALITY RATES
• Poor awareness levels resulting in ulcers being ignored by
many patients, consequently delaying diagnosis.
• Lack of overt presentation of symptoms and standard
screening tests results in poor detection rates.
• In addition, physicians, who are the first point of contact for
such patients, may not be adequately aware or trained to
detect and refer, or treat these patients.
15
16. PRIMARY CARE PHYSICIAN ROLE AS
“SECURITY OFFICER-
(FIRST CONTACT PERSON)”
in ONCOLOGY SERVICES
THE ROLE IN EARLY DIAGNOSIS
16
17. • Cancer screening and early detection.
• A major challenge for physicians:
– Symptoms of many cancers are common in the
community and overlap with prevalent benign
conditions.
• Physicians need to;
– Assess the risk, or diagnostic probability, of an
underlying cancer and determine whether further
investigation is justified. 17
18. 18
Ref: Jon D. Emery, et al. The role of primary care in early detection
and follow-up of cancer. 2014. Nat. Rev. Clin. Oncol. (11)38–48.
19. • Understanding of the epidemiology of cancer symptoms
in primary care:
– Analysis by UK general practice databases:
• QCancer Research:
–Freely available on websites www.qcancer.org
–Risk models for men and women that estimate
risks of multiple cancers according to baseline
risk factors, patterns of symptoms and specific
clinical conditions.
–It can be incorporated into English in physicians
computer systems of their potential clinical
utility.
19
Ref: Emery JD, et al. The role of primary care in early detection and follow-
up of cancer. 2014. Nat. Rev. Clin. Oncol. (11)38–48
20. • Primary care has a pivotal role in facilitating uptake
(by improve screening), which can be enhanced
using:
– Audit and feedback systems
– Office prompt systems
– General practitioner endorsement.
• Education and Training:
– Understanding of epidemiology of cancer symptoms.
– Risk models can be applied to identify patients requiring
investigation for cancer. 20
21. • Fast-track referral routes might be a useful approach
to reducing diagnostic delay in cancer.
• Primary care-led follow-up of breast and colorectal
cancer is as effective as hospital-led care, but
requires clear guidance for general practitioners, as
well as good communication and access to
specialists.
21
23. • Women having more clinician office visits were:
– 50% less likely to have late-stage cancer diagnosed.
– 41% lower breast cancer mortality.
– 27% lower overall mortality.
• Breast cancer Patients had better outcomes if they made
greater use of a primary care physician’s ambulatory
services, i.e.
– Including greater use of mammography
– Reduced odds of late stage diagnosis
– Lower breast cancer and overall mortality.
23
Ref: Roetzheim RG, et al. Influence of Primary Care on Breast Cancer Outcomes
Among Medicare Beneficiaries. 2012. Ann Fam Med;10:401-411.
24. Ref: Gale J. Inside India’s cancer epidemic. CancerWorld; (63) Nov-Dec 2014.
24
25. Forms in the
tissues of the
breast
BREAST CANCER
Spreads mainly
through the
Lymphatic system
25
27. • Not cancerous.
• Benign breast tumors are abnormal growths, but
they do not spread outside of the breast and they
are not life threatening.
BENIGN TUMORS
27
28. • Most lumps are caused by the combination of cysts and
fibrosis
• Cysts are fluid-filled sacs.
• Fibrosis is the formation of scar - like tissue.
• These changes can cause breast swelling and pain.
BENIGN TUMORS
28
30. • Breast cancer is a malignant (cancerous) tumor that
starts in the cells of the breast. It is found mostly in
women, but men can get breast cancer, too.
BREAST TUMORS
30
31. BREAST CANCER
Invasive
• Cancerous
• Malignant
• Spreads to other
organs (metastasis)
Non - Invasive
• Pre – Cancerous
• Still in its original
position
• Eventually develops into
invasive breast cancer.
31
32. GENDER - All
women are
at risk
Age
Family/Personal
History
Reproductive
History
Menstrual
HistoryRace
Genetic
Factors
Breast Cancer Risk Factors
unalterable factors
Radiation
Treatment with
DES
32
33. All
women are
at risk
Obesity
Breastfeeding
Not having
children
Birth Control
Pills
Alcohol
Hormone
Replacement
Therapy
Exercise
Obesity
Breastfeeding
Not having
children
Birth Control
Pills
Alcohol
Hormone
Replacement
Therapy
Breast Cancer Risk Factors
that can be controlled
Exercise
33
34. • Screening by mammography and physical examination
• Early Diagnosis: 25 to 30 % decrease in mortality over
age of 50 years & probably in btw age of 40-50 years.
• American Cancer Society, the National Cancer Institute
recommend;
– Annual Mammography For > 40 yrs
– High-risk families, with BRCA1 or BRCA2 mutant at;
• 25 years of age or 5 years earlier
• Standard method for confirming diagnosis:
• fine-needle aspiration or core needle biopsy
DIAGNOSTIC APPROACHES
34
35. Diagnostic tests and procedures for
breast cancer include:
• Breast exam
• Mammograms
• Breast ultrasound
• Breast MRI scan
• Biopsy
METHODS OF DIAGNOSIS
35
37. • Women in their 20s and 30s should have a clinical
breast exam every 3 years.
• After age 40, women should have a breast exam
every year
CLINICAL BREAST EXAMINATIONS
37
39. • BSE is an option for women starting in their 20s.
• Any changes detected should be reported to a
medical expert.
• BSE: Conducted standing or reclining
BREAST - SELF EXAMINATION
39
43. • An x-ray of the breast.
• It uses a very small amount of radiation.
Mammograms
screening diagnosis
MAMMOGRAMS
43
44. • A technologist will position your breast for the test.
• The breast is pressed between 2 plates to flatten and
spread the tissue.
• The pressure lasts only a few seconds while the picture
is taken.
• The breast and plates are repositioned and then another
picture is taken.
• The whole process takes about 20 minutes.
MAMMOGRAMS
44
47. • Uses sound waves to outline a part of the body.
• The sound wave echoes are picked up by a computer to
create a picture on a computer screen.
• Used to investigate areas of concerns found by a
mammogram.
BREAST ULTRASOUND
47
52. • It is estimated that 70% or 80% of cancer could be
controlled if preventive measures which primarily
involve lifestyle modification and early diagnostic
procedures could be instituted in all our population.
52
53. • PCPs must adopt an:
– Evidence based protocol
– Engage the patient
– Most importantly commit resources to
institutionalize clinical cancer prevention and early
detection policy.
• If the patient at risk can be convinced that:
– their lives will be longer, better, and more
productive because of prospective health care, they
will be more likely to seek this kind of care and
advice from their PCP on a continuing basis. 53
54. REFERENCES
1. Emery JD, et al. The role of primary care in early detection and follow-up of cancer. 2014. Nat. Rev.
Clin. Oncol. (11)38–48. Available online at: http : / / www.nature.com /nrclinonc /journal /v11
/n1/full/nrclinonc.2013.212.html
2. Klabunde CN, et al. The Role of Primary Care Physicians in Cancer Care. 2009. J Gen Intern Med
24(9):1029–36. Available online at: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2726889/
3. Gale J. Inside India’s cancer epidemic. CancerWorld; (63) Nov-Dec 2014. Available online at:
http://www.cancerworld.org / Articles /Issues /63/ November-December-2014/Best-Cancer-
Reporter-Award/688/Inside-Indias-cancer-epidemic.html
4. Roetzheim RG, et al. Influence of Primary Care on Breast Cancer Outcomes Among Medicare
Beneficiaries. 2012. Ann Fam Med;10:401-411. Available online at:
http://www.ncbi.nlm.nih.gov/pubmed/22966103
5. American Cancer Society Breast Cancer Screening Guideline (2015). Available online at:
http://www.cancer.org/ healthy/ information for health care professionals /acsguidelines
/breastcancerscreeningguidelines/index
6. Call for Action: Expanding cancer care in India. 2015. Executive Summary. Available online at:
http://www.ey.com/Publication/vwLUAssets/EY-Call-for-action-expanding-cancer-care-in-
india/$FILE/EY-Call-for-action-expanding-cancer-care-in-india.pdf
54